| Primary |
| Product Used For Unknown Indication |
70.6% |
| Hypertension |
16.9% |
| Blood Pressure |
1.6% |
| Blood Cholesterol Increased |
1.0% |
| Blood Pressure Increased |
1.0% |
| Hepatitis C |
0.8% |
| Metabolic Syndrome |
0.8% |
| Muscle Spasms |
0.8% |
| Retroviral Infection |
0.8% |
| Spinal Anaesthesia |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
| Anxiety |
0.5% |
| Cerebrovascular Accident |
0.5% |
| Depression |
0.5% |
| Diabetes Mellitus |
0.5% |
| Dyspepsia |
0.5% |
| Epilepsy |
0.5% |
| Mineral Supplementation |
0.5% |
| Accidental Exposure To Product By Child |
0.3% |
| Anaemia |
0.3% |
|
| Completed Suicide |
33.9% |
| Loose Tooth |
5.1% |
| Pain In Extremity |
5.1% |
| Vision Blurred |
5.1% |
| Death |
3.4% |
| Erectile Dysfunction |
3.4% |
| Headache |
3.4% |
| Hypotension |
3.4% |
| Joint Swelling |
3.4% |
| Local Swelling |
3.4% |
| Loss Of Consciousness |
3.4% |
| Malaise |
3.4% |
| Muscle Spasms |
3.4% |
| Oedema Peripheral |
3.4% |
| Overdose |
3.4% |
| Somnolence |
3.4% |
| Visual Impairment |
3.4% |
| Weight Increased |
3.4% |
| Back Pain |
1.7% |
| Breast Pain |
1.7% |
|
| Secondary |
| Product Used For Unknown Indication |
68.9% |
| Hypertension |
16.7% |
| Drug Use For Unknown Indication |
3.2% |
| Blood Cholesterol Increased |
2.7% |
| Type 2 Diabetes Mellitus |
1.8% |
| Coronary Artery Disease |
1.4% |
| Blood Pressure |
0.9% |
| Osteoarthritis |
0.9% |
| Abdominal Discomfort |
0.5% |
| Hypercholesterolaemia |
0.5% |
| Hypothyroidism |
0.5% |
| Muscle Spasms |
0.5% |
| Rheumatoid Arthritis |
0.5% |
| Sinusitis |
0.5% |
| Supraventricular Tachycardia |
0.5% |
| Thrombosis Prophylaxis |
0.5% |
|
| Completed Suicide |
22.2% |
| Vomiting |
13.9% |
| Renal Disorder |
8.3% |
| Myalgia |
5.6% |
| Oedema Peripheral |
5.6% |
| Renal Failure Acute |
5.6% |
| Deep Vein Thrombosis |
2.8% |
| Diabetes Mellitus |
2.8% |
| Dysgeusia |
2.8% |
| Eczema |
2.8% |
| Epistaxis |
2.8% |
| Lichenoid Keratosis |
2.8% |
| Liver Function Test Abnormal |
2.8% |
| Memory Impairment |
2.8% |
| Neuropathy Peripheral |
2.8% |
| Osteoarthritis |
2.8% |
| Pancreatitis Necrotising |
2.8% |
| Paraesthesia |
2.8% |
| Peroneal Nerve Palsy |
2.8% |
| Presyncope |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
46.7% |
| Hypertension |
13.3% |
| Arrhythmia Prophylaxis |
6.7% |
| Blood Cholesterol Increased |
6.7% |
| Chronic Pulmonary Heart Disease |
6.7% |
| Hypercholesterolemia |
6.7% |
| Off Label Use |
6.7% |
| Pulmonary Tuberculosis |
6.7% |
|
| Angioedema |
7.1% |
| Cataract |
7.1% |
| Confusional State |
7.1% |
| Glomerular Filtration Rate Decreased |
7.1% |
| Hallucination |
7.1% |
| Hot Flush |
7.1% |
| Hypersensitivity Vasculitis |
7.1% |
| Myocardial Infarction |
7.1% |
| Myoclonus |
7.1% |
| Orthopnoea |
7.1% |
| Renal Failure Acute |
7.1% |
| Syncope |
7.1% |
| Urticaria |
7.1% |
| Vision Blurred |
7.1% |
|
| Interacting |
| Hypertension |
41.7% |
| Product Used For Unknown Indication |
41.7% |
| Diuretic Therapy |
8.3% |
| Hypercholesterolaemia |
8.3% |
|
| Vomiting |
50.0% |
| White Blood Cell Count Increased |
50.0% |
|
